Pneumonia Guide vs Sepsis Clinical Guide

Pneumonia Guide distills and organizes the guidance found in the 2019, 2016, 2007, and 2005 American Thoracic Society & Infectious Disease Society of America guidelines on management of Community Acquired Pneumonia and Hospital Acquired Pneumonia and the 2011 IDSA Pediatric Community Acquired Pneumonia guideline. The app addresses such common questions as: * what criteria are useful in deciding which community acquired pneumonia patients should be hospitalized? * what are those big-gun antibiotics for adult hospital acquired pneumonia, and what are the alternatives for those with medication allergies? * how long should antibiotics be continued? * exactly which pneumonia cases are considered to be hospital acquired? * which community acquired pneumonia patients require coverage for resistant organisms? * which hospitalized patients should be in the ICU? * which antibiotics are appropriate initial therapy for children with pneumonia? This app is written and intended for practicing clinicians like family physicians, internists, pediatricians, ER docs, and hospitalists; for resident physician trainees; and for medical students. As an educator and clinician, I am interested in feedback and I would be grateful for guidance on improving the tool.

Sepsis Clinical Guide now includes access the new ESCAVO Clinical Community, a forum where clinicians can exchange ideas, ask questions and collaborate on sepsis and other clinical topics. Sepsis is a serious systemic infection that can quickly lead to circulatory shock, organ failure and death if inappropriately treated. In 2017, over 2 million people were admitted to US hospitals for sepsis (#1 cause of index admissions) at a total aggregate cost to the US healthcare system of $38.2 billion dollars (#1 most expensive condition), according to an AHRQ report. Over 270,000 people die of sepsis in the US every year, more than from prostate cancer, breast cancer and AIDS combined. Despite its large toll on public health, public awareness of this condition is poor and the quality of treatment is highly variable often due to delayed recognition and treatment. In sepsis, time is of the essence. Successful treatment hinges on prompt recognition of symptoms, correct antibiotic administration, and hemodynamic stabilization. Lack of appropriate sepsis management knowledge at the bedside leads to delayed symptom recognition, serious complications, medical errors, increased treatment costs, and avoidable morbidity and mortality. For this reason, we created this app to provide busy health professionals with essential management information based on the latest practice guidelines in a format that is easily accessible at the point of care. The Sepsis app was developed on the ESCAVO mobile publishing platform created specifically for mobile publishing of scientific content. The platform features an intuitive user interface, search, annotation and bookmarking functions, and calculator support. All content is extensively referenced and footnoted where appropriate. Clinical topics covered in the Sepsis app include: - Updated with the latest definitions, diagnostic criteria, and management guidelines including the 2016 Sepsis-3 definitions and the latest Surviving Sepsis Campaign (SSC) guidelines - Epidemiology, risk factors and pathophysiology of sepsis and septic shock - Common differentials and etiology, guidelines on performing appropriate H&P and workups - Management of common causes including hospital-acquired pneumonia (HAP), ventilator-acquired pneumonia (VAP) and intra-abdominal infections - Sepsis management bundles, early goal-directed therapy, hemodynamic management, adjunctive therapies, mechanical ventilation of sepsis-induced ARDS, and other essential management guidelines from the SSC and the American Thoracic Society (ATS) - Antibiotic therapy including specific guidelines for the treatment of HAP from ATS and the Infectious Diseases Society of America (IDSA) - Guidance on the prevention, recognition and treatment of Clostridium difficile based on the latest IDSA guidelines - Information on the diagnosis and management of pediatric and neonatal sepsis including the management of pediatric fever, important differences from adult sepsis, management of sepsis-induced persistent pulmonary hypertension of the newborn (PPHN), empiric antibiotic treatment recommendations for GBS infections, interventions in pediatric septic shock, and other pediatric-specific information - Important score calculators including the Sequential Organ Failure Assessment (SOFA), quick-SOFA, SIRS, APACHE II, Multiple Organ Dysfunction Score (MODS), the Simplified Acute Physiology Score (SAPS) II, National Early Warning Score (NEWS), the Clinical Pulmonary Infection (CPI) score, the Inferior Vena Cava Collapsibility Index, and others - Drug administration information for the management of sepsis including antibacterial and antifungal antibiotics, the latest drugs for emerging multi-drug resistant organisms, adrenergic and other vasoactive agents, corticosteroids and diuretics - Relevant COVID-19 management information Recommended by: - HealthTap.com - MDLinx.com - imedicalapps.com - The ED Trauma Critical Care Blog (edtcc.com)